MedPath

Efficacy of NIV Masks in COPD

Not Applicable
Completed
Conditions
COPD
Interventions
Device: Investigation Mask
Device: Comparator Mask
Registration Number
NCT04947852
Lead Sponsor
Fisher and Paykel Healthcare
Brief Summary

A randomized controlled pilot study to compare the efficacy and tolerability of a two different NIV masks on carbon dioxide in participants with stable chronic obstructive pulmonary disease (COPD) with chronic type II respiratory failure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • A doctor's diagnosis of COPD
  • PtCO2 ≥45mmHg on transcutaneous monitor at baseline measure
  • Oxygen saturation measured by pulse oximetry (SpO2) ≥85%
  • Fits the study mask
  • Can tolerate the therapy
Exclusion Criteria
  • FEV1/FVC ≥70%
  • Body mass index >35
  • Hypercapnia considered to be primarily due to Obesity Hypoventilation syndrome and/or Obstructive Sleep Apnea
  • Any condition which makes NIV contra-indicated as per BTS guidelines based on clinical judgement

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Investigation MaskComparator MaskBi Level CPAP Mask
Comparator MaskComparator MaskBi Level CPAP Mask
Comparator MaskInvestigation MaskBi Level CPAP Mask
Investigation MaskInvestigation MaskBi Level CPAP Mask
Primary Outcome Measures
NameTimeMethod
Transcutaneous Carbon Dioxide60 minutes

mmHg

Secondary Outcome Measures
NameTimeMethod
Minute Ventilation60 minutes

Litres

Respiratory Rate60 minutes

Breaths per minute

Oxygen Saturation60 minutes

Percentage

Heart Rate60 minutes

Beats per minute

Borg Dyspnoea Score60 Minutes

1-6 Ranking, with 1 being best and 6 being worst

Trial Locations

Locations (1)

Medical Research Institute New Zealand

🇳🇿

Wellington, New Zealand

© Copyright 2025. All Rights Reserved by MedPath